These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22559745)

  • 1. Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin.
    Asadi S; Theoharides TC
    J Neuroinflammation; 2012 May; 9():85. PubMed ID: 22559745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells.
    Weng Z; Patel AB; Panagiotidou S; Theoharides TC
    J Allergy Clin Immunol; 2015 Apr; 135(4):1044-1052.e5. PubMed ID: 25498791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin Is More Potent than Cromolyn in Their Ability to Inhibit Mediator Release from Cultured Human Mast Cells.
    Tsilioni I; Theoharides T
    Int Arch Allergy Immunol; 2024; 185(8):803-809. PubMed ID: 38588651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin and CRH interactions augment human mast cell activation.
    Alysandratos KD; Asadi S; Angelidou A; Zhang B; Sismanopoulos N; Yang H; Critchfield A; Theoharides TC
    PLoS One; 2012; 7(11):e48934. PubMed ID: 23155429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is a subtype of autism an allergy of the brain?
    Theoharides TC
    Clin Ther; 2013 May; 35(5):584-91. PubMed ID: 23688533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor.
    Cao J; Papadopoulou N; Kempuraj D; Boucher WS; Sugimoto K; Cetrulo CL; Theoharides TC
    J Immunol; 2005 Jun; 174(12):7665-75. PubMed ID: 15944267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway.
    Cao J; Cetrulo CL; Theoharides TC
    Mol Pharmacol; 2006 Mar; 69(3):998-1006. PubMed ID: 16332989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute stress and intravesical corticotropin-releasing hormone induces mast cell dependent vascular endothelial growth factor release from mouse bladder explants.
    Cao J; Boucher W; Kempuraj D; Donelan JM; Theoharides TC
    J Urol; 2006 Sep; 176(3):1208-13. PubMed ID: 16890727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions.
    Zhang B; Asadi S; Weng Z; Sismanopoulos N; Theoharides TC
    PLoS One; 2012; 7(12):e49767. PubMed ID: 23284625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cells.
    Vasiadi M; Therianou A; Alysandratos KD; Katsarou-Katsari A; Petrakopoulou T; Theoharides A; Papadavid E; Stavrianeas N; Antoniou C; Kalogeromitros D; Theoharides TC
    Br J Dermatol; 2012 Jun; 166(6):1349-52. PubMed ID: 22283733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells.
    Asadi S; Alysandratos KD; Angelidou A; Miniati A; Sismanopoulos N; Vasiadi M; Zhang B; Kalogeromitros D; Theoharides TC
    J Invest Dermatol; 2012 Feb; 132(2):324-9. PubMed ID: 22089831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli.
    Vasiadi M; Kalogeromitros D; Kempuraj D; Clemons A; Zhang B; Chliva C; Makris M; Wolfberg A; House M; Theoharides TC
    Int Arch Allergy Immunol; 2010; 151(1):38-45. PubMed ID: 19672095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin inhibits mast cell-mediated allergic inflammation.
    Kritas SK; Saggini A; Varvara G; Murmura G; Caraffa A; Antinolfi P; Toniato E; Pantalone A; Neri G; Frydas S; Rosati M; Tei M; Speziali A; Saggini R; Pandolfi F; Cerulli G; Theoharides TC; Conti P
    J Biol Regul Homeost Agents; 2013; 27(4):955-9. PubMed ID: 24382176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing hormone-receptor 2 is required for acute stress-induced bladder vascular permeability and release of vascular endothelial growth factor.
    Boucher W; Kempuraj D; Michaelian M; Theoharides TC
    BJU Int; 2010 Nov; 106(9):1394-9. PubMed ID: 20201838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab inhibits acceleration of FcεRI-mediated responsiveness of immature human mast cells by immunoglobulin E.
    Okayama Y; Kashiwakura J; Sasaki-Sakamoto T; Matsumoto K; Hashimoto N; Ohmori K; Kawakami T; Saito H; Ra C
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):188-94. PubMed ID: 22374203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists.
    Lytinas M; Kempuraj D; Huang M; Boucher W; Esposito P; Theoharides TC
    Int Arch Allergy Immunol; 2003 Mar; 130(3):224-31. PubMed ID: 12660427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Ca2+ flux is a critical determinant of the Ca2+ dependence of mast cell degranulation.
    Suzuki Y; Yoshimaru T; Inoue T; Ra C
    J Leukoc Biol; 2006 Mar; 79(3):508-18. PubMed ID: 16365155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells.
    Kempuraj D; Tagen M; Iliopoulou BP; Clemons A; Vasiadi M; Boucher W; House M; Wolfberg A; Theoharides TC
    Br J Pharmacol; 2008 Dec; 155(7):1076-84. PubMed ID: 18806808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders.
    Theoharides TC; Athanassiou M; Panagiotidou S; Doyle R
    J Neuroimmunol; 2015 Feb; 279():33-8. PubMed ID: 25669997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells.
    Kimata M; Shichijo M; Miura T; Serizawa I; Inagaki N; Nagai H
    Clin Exp Allergy; 2000 Apr; 30(4):501-8. PubMed ID: 10718847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.